Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06843707
What this trial is testing

Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.

Who this might be right for
Lung CancerLungLung Cancer (NSCLC)+1 more
The First Affiliated Hospital of Guangzhou Medical University 2,500
Testing effectiveness (Phase 2)Study completedNCT00192036
What this trial is testing

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 49
Testing effectiveness (Phase 2)UnknownNCT05055167
What this trial is testing

Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IV
The First Affiliated Hospital of Xiamen University 20
Not applicableStudy completedNCT02650700
What this trial is testing

Spleen Radiotherapy Decreases Severe CIT in Advanced NSCLC (SPLEENIR)

Who this might be right for
Chemotherapy in Non-Small Cell Lung Cancer
Xinqiao Hospital of Chongqing 100
Not applicableLooking for participantsNCT06221800
What this trial is testing

Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

Who this might be right for
Non Small Cell Lung Cancer
University of California, Irvine 82
Early research (Phase 1)Study completedNCT02009436
What this trial is testing

Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Albert Einstein College of Medicine 8
Not applicableUnknownNCT02965300
What this trial is testing

The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis

Who this might be right for
Lung NeoplasmLung Disease
Chinese PLA General Hospital 230
Testing effectiveness (Phase 2)UnknownNCT05267392
What this trial is testing

Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy

Who this might be right for
Non-small Cell Lung Cancer
Instituto Portugues de Oncologia, Francisco Gentil, Porto 30
Large-scale testing (Phase 3)WithdrawnNCT03048136
What this trial is testing

A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Not applicableEnded earlyNCT02551211
What this trial is testing

Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer

Who this might be right for
Resectable Non-small Lung Cancer
University Hospital, Rouen 22
Testing effectiveness (Phase 2)Study completedNCT02169271
What this trial is testing

Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules

Who this might be right for
Current SmokerFormer SmokerMultiple Pulmonary Nodules+1 more
National Cancer Institute (NCI) 109
Testing effectiveness (Phase 2)Study completedNCT03562871
What this trial is testing

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

Who this might be right for
NSCLC
IO Biotech 109
Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Not applicableNo Longer AvailableNCT01947608
What this trial is testing

Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT01346540
What this trial is testing

A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 16
Not applicableStudy completedNCT01855191
What this trial is testing

SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation

Who this might be right for
Lung Cancer
Maastricht Radiation Oncology 864
Testing effectiveness (Phase 2)Ended earlyNCT00321308
What this trial is testing

Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Pfizer 36
Not applicableUnknownNCT01814150
What this trial is testing

The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel

Who this might be right for
Metastatic Lung CancerMetastatic Breast CancerMetastatic Gastric Cancer+2 more
Gottfried Maya 200
Testing effectiveness (Phase 2)Study completedNCT01844791
What this trial is testing

An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer
Oncozyme Pharma Inc. 25
Not applicableStudy completedNCT05883735
What this trial is testing

Retrospective Study of Radio-induced Toxicities in the Treatment of Lung Cancer With Tomotherapy

Who this might be right for
Lung Cancer
Centre Hospitalier Régional Metz-Thionville 318
Next Page